PT  - JOURNAL ARTICLE
AU  - Ready, Neal E
AU  - Audigier-Valette, Clarisse
AU  - Goldman, Jonathan W
AU  - Felip, Enriqueta
AU  - Ciuleanu, Tudor-Eliade
AU  - Rosario García Campelo, María
AU  - Jao, Kevin
AU  - Barlesi, Fabrice
AU  - Bordenave, Stéphanie
AU  - Rijavec, Erika
AU  - Urban, Laszlo
AU  - Aucoin, Jean-Sébastien
AU  - Zannori, Cristina
AU  - Vermaelen, Karim
AU  - Arén Frontera, Osvaldo
AU  - Curioni Fontecedro, Alessandra
AU  - Sánchez-Gastaldo, Amparo
AU  - Juan-Vidal, Oscar
AU  - Linardou, Helena
AU  - Poddubskaya, Elena
AU  - Spigel, David R
AU  - Ahmed, Samreen
AU  - Maio, Michele
AU  - Li, Sunney
AU  - Chang, Han
AU  - Fiore, Joseph
AU  - Acevedo, Angelic
AU  - Paz-Ares, Luis
TI  - First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817
AID  - 10.1136/jitc-2022-006127
DP  - 2023 Feb 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e006127
VI  - 11
IP  - 2
4099  - http://jitc.bmj.com/content/11/2/e006127.short
4100  - http://jitc.bmj.com/content/11/2/e006127.full
SO  - J Immunother Cancer2023 Feb 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.